EUDA Health Holdings Limited — Form 6-K Summary
Reporting period: Form 6-K dated May 7, 2024, covering the month of May 2024. The filing reports a material acquisition agreement announced May 6, 2024.
Business Context and Transaction
EUDA entered into a Share Purchase Agreement to acquire all outstanding shares of Fortress Cove Limited, a British Virgin Islands company that wholly owns CK Health Plus Sdn Bhd, a Malaysian direct-sale business focused on holistic wellness consumer products.
- EUDA will acquire the entire issued capital of CK Health through the issuance of 10,000,000 new ordinary shares.
- The consideration shares are valued at $15.0 million.
- Up to 1,000,000 additional ordinary shares may be issued if CK Health meets specified net-income milestones for fiscal years 2024 and 2025.
- Closing was expected on May 8, 2024, subject to customary closing conditions.
- EUDA agreed to file an SEC resale registration statement covering the consideration shares and any additional consideration shares.
Financial Metrics and Capitalization
The filing does not provide current-period revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics for EUDA or CK Health. The $15.0 million transaction value represents the stated value of the 10,000,000 consideration shares and is not reported as cash consideration.
The transaction will increase EUDA’s shares outstanding by 10,000,000 shares at closing, with potential additional dilution of up to 1,000,000 shares tied to CK Health’s 2024 and 2025 net-income performance.
Material Changes, Outlook, and Risks
- The acquisition expands EUDA’s business into Malaysia’s direct-sale holistic wellness consumer-products market.
- Completion remained subject to customary closing conditions as of the filing date.
- Additional consideration shares depend on CK Health achieving contractual net-income milestones; the filing text does not provide the milestone amounts.
- A significant EUDA shareholder is also a significant shareholder of Fortress Cove, creating a related-party or conflict-of-interest consideration for investors.
- The acquisition agreement and company press release are incorporated into the filing as Exhibits 10.1 and 99.1.
Key Facts for Investors to Verify
- Whether the acquisition closed on or after May 8, 2024 and whether all closing conditions were satisfied.
- The final number of EUDA shares issued and the resulting ownership dilution.
- The specific 2024 and 2025 net-income milestones governing the additional 1,000,000 shares.
- CK Health’s historical and projected revenue, profitability, cash flow, debt, and liquidity.
- The nature and terms of any related-party arrangements involving EUDA and Fortress Cove shareholders.
- The filing and effectiveness status of the resale registration statement.